1) Altshuler LL, Suppes T, Black DO, et al:Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry 163:313-315, 2006
2) Amsterdam JD, Brunswick DJ:Antidepressant monotherapy for bipolar type II major depression. Bipolar Disord 5:388-395, 2003
3) Baldessarini RJ, Faedda GL, Offidani E, et al:Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder:A review. J Affect Disord 148:129-135, 2013
4) Cohn JB, Collins G, Ashbrook E, et al:A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 4:313-322, 1989
5) Crump C, Sundquist K, Winkleby MA, et al:Comorbidities and mortality in bipolar disorder:A Swedish national cohort study. JAMA Psychiatry 70:931-939, 2013
6) Gijsman HJ, Geddes JR, Rendell JM, et al:Antidepressants for bipolar depression:A systematic review of randomized, controlled trials. Am J Psychiatry 161:1537-1547, 2004
7) Goldberg JF, Perlis RH, Ghaemi SN, et al:Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms:Findings from the STEP-BD. Am J Psychiatry 164:1348-1355, 2007
8) Grunze H, Vieta E, Goodwin GM, et al:The World Federation of Societies of Biological Psychiatry(WFSBP)Guidelines for the Biological Treatment of Bipolar Disorders:Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 11:81-109, 2010
9) Inoue T, Kitaichi Y, Masui T, et al:Pramipexole for stage 2 treatment-resistant major depression:An open study. Prog Neuropsychopharmacol Biol Psychiatry 34:1446-1449, 2010
10) Inoue T, Abekawa T, Nakagawa S, et al:Long-term naturalistic follow-up of lithium augmentation:Relevance to bipolarity. J Affect Disord 129:64-67, 2011
11) Morishita S, Arita S. Treatment of bipolar II depression with milnacipran, fluvoxamine, paroxetine, or maprotiline. Intern Med J 12:283-285, 2005
12) Nemeroff CB, Evans DL, Gyulai L, et al:Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 158:906-912, 2001
13) Post RM, Altshuler LL, Leverich GS, et al:Mood switch in bipolar depression:Comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 189:124-131, 2006, Erratum in:Br J Psychiatry 189:569, 2006
14) Sachs GS, Nierenberg AA, Calabrese JR, et al:Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 356:1711-1722, 2007
15) Vieta E, Martinez-Arán A, Goikolea JM, et al:A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 63:508-512, 2002
16) Viktorin A, Lichtenstein P, Thase ME, et al:The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry 171:1067-1073, 2014
17) Yatham LN, Kennedy SH, Parikh SV, et al:Canadian Network for Mood and Anxiety Treatments(CANMAT)and International Society for Bipolar Disorders(ISBD)collaborative update of CANMAT guidelines for the management of patients with bipolar disorder:Update. Bipolar Disord 15:1-44, 2013